Oprelvekin and Arrhythmias
Result of checking the interaction of drug Oprelvekin and disease Arrhythmias for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Transient artrial arrhythmias (fibrillation and flutter) have occurred in approximately 10% of patients receiving oprelvekin. Cardiac conditions, previous cardiotoxic chemotherapy, or advanced age are considered risk factors for development of oprelvekin- associated arrhythmias. Therapy with oprelvekin should be administered cautiously in patients with or predisposed to artrial arrhythmias.
- "Product Information. Neumega (oprelvekin)." Genetics Institute, Cambridge, MA.